Market Overview:
The global eye allergy treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergies, increasing awareness about eye allergies, and technological advancements in the field of ophthalmology. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. The global eye allergy treatment market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into medication, allergy shots, and others (including immunotherapy). The medication segment is further sub-segmented into antihistamines/antihistamine drops/nasal sprays; decongestants; mast cell stabilizers; corticosteroids; and Others (including leukotriene modifiers and chromones). The antihistamines/antihistamine drops/nasal sprays sub-segment accounted for a major share in 2017 owing to their wide use for treating various types of allergies. On the basis on application, it can be classified into hospitals and eye clinics.
Product Definition:
Eye allergy treatment is the use of medications or other therapies to relieve symptoms of eye allergies. Eye allergy treatment is important because it can help reduce symptoms and improve quality of life.
Medication:
Medication, its usage and growth factor in the market for eye allergy treatment is a study carried out to determine the effectiveness of various anti-allergic agents used for treating allergic conditions. The study includes allergen extracts such as tree nut, peanut, grasses and others. The research methodology adopted in this study includes double blind cross-over clinical trial using medication which is already approved by the Food and Drug Administration (FDA) for treating Allergic rhinitis (AR).
Allergy Shots:
Allergy shots are also known as immunotherapy or allergy vaccines. It is a series of small doses of allergen extracts that induce an immune response to the allergen. The treatment is used for treating allergic conditions such as hay fever, asthma, and eczema. This therapy aims at changing the way the immune system reacts to certain substances (allergens).
Application Insights:
Based on application, the global market is segmented into hospitals and eye clinics. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at a large scale. In addition, hospital-based allergy treatment services are more effective as compared to those offered by an allergist or Allergy Clinics.
The eye clinics segment is expected to witness lucrative growth over the forecast period due to increasing number of patients with allergies affecting eyesight seeking medical consultation and treatment from an ophthalmologist or optometrist. Moreover, these professionals offer complete diagnosis along with effective treatments for different types of allergies including food allergy, environmental allergy and airborne allergies that affect eyesight directly or indirectly through another organ system such as respiratory tract or skin barrier function. This factor is anticipated to boost demand for allergen extractor machines which can be used for efficient extraction of allergenic extracts from various animal sources such as cat dander, dog hair etc.
Regional Analysis:
North America dominated the global eye allergy treatment market in 2017. The presence of well-established healthcare infrastructure, high awareness levels coupled with the availability of highly effective and advanced medication for treating allergic conditions are some factors responsible for its large share. In addition, increasing prevalence of various allergic disorders such as eczema and atopic dermatitis is also expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income leading to an increase in consumer access towards better quality treatment options such as allergen immunotherapy which has a higher cost than generic drugs or OTC products. Moreover, growing medical tourism industry due to low costs associated with receiving treatments in emerging countries will further propel market demand during the forecast period (2018 - 2030).
Growth Factors:
- Increasing prevalence of eye allergies
- Growing awareness about the treatment and management of eye allergies
- Rising demand for ophthalmic drugs and devices
- Technological advancements in the field of ophthalmology
- Growing number of mergers and acquisitions in the eye allergy treatment market
Scope Of The Report
Report Attributes
Report Details
Report Title
Eye Allergy Treatment Market Research Report
By Type
Medication, Allergy Shots, Others
By Application
Hospitals, Eye Clinics
By Companies
ALLERGAN, Johnson & Johnson Vision Care, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, Santen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Eye Allergy Treatment Market Report Segments:
The global Eye Allergy Treatment market is segmented on the basis of:
Types
Medication, Allergy Shots, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Eye Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALLERGAN
- Johnson & Johnson Vision Care
- Merck
- Novartis
- Pfizer
- Regeneron Pharmaceuticals
- Roche
- Santen Pharmaceutical
Highlights of The Eye Allergy Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Allergy Shots
- Others
- By Application:
- Hospitals
- Eye Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eye Allergy Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eye allergy treatment is a type of medication that helps to reduce the symptoms of eye allergies. Treatment options may include prescription medications, over-the-counter medications, and natural remedies.
Some of the key players operating in the eye allergy treatment market are ALLERGAN, Johnson & Johnson Vision Care, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, Santen Pharmaceutical.
The eye allergy treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eye Allergy Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eye Allergy Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eye Allergy Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eye Allergy Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eye Allergy Treatment Market Size & Forecast, 2020-2028
4.5.1 Eye Allergy Treatment Market Size and Y-o-Y Growth
4.5.2 Eye Allergy Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Medication
5.2.2 Allergy Shots
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Eye Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eye Allergy Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eye Allergy Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Medication
9.6.2 Allergy Shots
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Eye Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Medication
10.6.2 Allergy Shots
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Eye Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Medication
11.6.2 Allergy Shots
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Eye Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Medication
12.6.2 Allergy Shots
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Eye Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Medication
13.6.2 Allergy Shots
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Eye Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eye Allergy Treatment Market: Competitive Dashboard
14.2 Global Eye Allergy Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALLERGAN
14.3.2 Johnson & Johnson Vision Care
14.3.3 Merck
14.3.4 Novartis
14.3.5 Pfizer
14.3.6 Regeneron Pharmaceuticals
14.3.7 Roche
14.3.8 Santen Pharmaceutical
